Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BELUMOSUDIL MESYLATE, with a corresponding US DMF Number 41083.
Remarkably, this DMF maintains an Active status since its submission on March 06, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 17, 2025, and payment made on February 20, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II